Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human nerve growth factor

EU orphan designation number: EU/3/13/1135   
Active ingredient: Recombinant human nerve growth factor
Indication: Treatment of retinitis pigmentosa
Sponsor: Dompé S.p.A.
Via Campo di Pile, 67100 L'Aquila, Italia

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Centralised Orphan - Designation EMA/OD/015/13 (2013)3670 of 07/06/2013